skip to main content

104. FDA Additional Safeguards for Children in Clinical Investigations (§50, Subpart D)

21 CFR 50 Subpart D mirrors the requirements described in Subpart D of the DHHS regulations but uses "clinical investigation" instead of "research." See the IRB policy manual for research with children for information about categories of research and requirements for parental consent and child assent.

Take the next step...